Crossmark

Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects

Crossref DOI link: https://doi.org/10.1038/s42003-022-03605-4

Published Online: 2022-07-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takashima, Masamitsu

Nakamura, Kuniyuki https://orcid.org/0000-0002-9918-8802
Kiyohara, Takuya

Wakisaka, Yoshinobu https://orcid.org/0000-0002-5757-0894
Hidaka, Masaoki

Takaki, Hayato

Yamanaka, Kei

Shibahara, Tomoya

Wakisaka, Masanori

Ago, Tetsuro

Kitazono, Takanari
Funding

Funding for this research was provided by:

MEXT | Japan Society for the Promotion of Science (C 19K09511)

MEXT | Japan Society for the Promotion of Science (C 22K09236)

MEXT | Japan Society for the Promotion of Science (C 26462163)

MEXT | Japan Society for the Promotion of Science (C 19K09530)

MEXT | Japan Society for the Promotion of Science (C 22K09209)

MEXT | Japan Society for the Promotion of Science (21K20693)

MEXT | Japan Society for the Promotion of Science (B 16H05439)

MEXT | Japan Society for the Promotion of Science (B 20H03791)

MEXT | Japan Society for the Promotion of Science (C 20K09373)

MEXT | Japan Society for the Promotion of Science (B 16H05439)

MEXT | Japan Society for the Promotion of Science (B 20H03791)

Mochida Memorial Foundation for Medical and Pharmaceutical Research

SENSHIN Medical Research Foundation

Smoking Research Foundation
License Information

Text and Data Mining valid from 2022-07-02

Version of Record valid from 2022-07-02
More Information

Article History

Received: 15 August 2021

Accepted: 20 June 2022

First Online: 2 July 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below